CONVENIENCE TRANSLATION INTO ENGLISH OF CONSOLIDATED FINANCIAL STATEMENTS
ORIGINALLY ISSUED IN TURKISH
DOĞAN ŞİRKETLER GRUBU HOLDİNG A.Ş.
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE INTERIM PERIOD ENDED 1 JANUARY - 30 SEPTEMBER 2022
DOĞAN ŞİRKETLER GRUBU HOLDİNG A.Ş. | ||
CONTENTS | PAGES | |
CONSOLIDATED STATEMENT OF FINANCIAL POSITION.......................................... | 1-2 | |
CONSOLIDATED STATEMENT OF PROFIT OR LOSS.................................................... | 3 | |
CONSOLIDATED STATEMENT OF OTHER COMPREHENSIVE INCOME ................ | 4 | |
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY ........................................... | 5-6 | |
CONSOLIDATED STATEMENT OF CASH FLOW............................................................. | 7-8 | |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS .................................... | 9-135 | |
NOTE 1 | ORGANIZATION AND NATURE OF OPERATIONS ........................................................................ | 9-11 |
NOTE 2 | BASIS OF PRESENTATION OF FINANCIAL STATEMENTS .......................................................... | 12-49 |
NOTE 3 | BUSINESS COMBINATIONS............................................................................................................... | 50-56 |
NOTE 4 | INVESTMENTS ACCOUNTED FOR BY THE EQUITY METHOD .................................................. | 57-62 |
NOTE 5 | SEGMENT REPORTING....................................................................................................................... | 63-69 |
NOTE 6 | CASH AND CASH EQUIVALENTS .................................................................................................... | 70 |
NOTE 7 | FINANCIAL INVESTMENTS............................................................................................................... | 71-72 |
NOTE 8 | SHORT AND LONG TERM FINANCIAL BORROWINGS ................................................................ | 73-77 |
NOTE 9 | TRADE RECEIVABLES AND PAYABLES......................................................................................... | 77-78 |
NOTE 10 | RECEIVABLES AND PAYABLES FROM FINANCE SECTOR OPERATIONS ............................... | 79-80 |
NOTE 11 | OTHER RECEIVABLES AND PAYABLES......................................................................................... | 81 |
NOTE 12 | INVENTORIES ...................................................................................................................................... | 82 |
NOTE 13 | BIOLOGICAL ASSETS ......................................................................................................................... | 82 |
NOTE 14 | INVESTMENT PROPERTIES ............................................................................................................... | 83-84 |
NOTE 15 | PROPERTY, PLANT AND EQUIPMENT ............................................................................................ | 85-86 |
NOTE 16 | INTANGIBLE ASSETS ......................................................................................................................... | 87-89 |
NOTE 17 | RIGHT OF USE ASSETS....................................................................................................................... | 89-90 |
NOTE 18 | GOVERNMENT GRANTS .................................................................................................................... | 90 |
NOTE 19 | PROVISIONS, CONTINGENT ASSETS AND LIABILITIES ............................................................. | 91-93 |
NOTE 20 | COMMITMENTS................................................................................................................................... | 94-95 |
NOTE 21 | OTHER ASSETS .................................................................................................................................... | 96 |
NOTE 22 | PREPAID EXPENSES AND DEFERRED INCOME ............................................................................ | 96-97 |
NOTE 23 | DERIVATIVE INSTRUMENTS ............................................................................................................ | 97 |
NOTE 24 | PROVISION FOR EMPLOYMENT BENEFITS ................................................................................... | 98-99 |
NOTE 25 | EQUITY.................................................................................................................................................. | 100-104 |
NOTE 26 | REVENUE AND COST OF SALES ...................................................................................................... | 105-109 |
NOTE 27 | RESEARCH AND DEVELOPMENT EXPENSES, MARKETING EXPENSES AND | |
GENERAL ADMINISTRATIVE EXPENSES....................................................................................... | 109-110 | |
NOTE 28 | EXPENSES BY NATURE ..................................................................................................................... | 110 |
NOTE 29 | OTHER INCOME AND EXPENSES FROM OPERATING ACTIVITIES .......................................... | 110-111 |
NOTE 30 | INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES...................................................... | 111 |
NOTE 31 | FINANCE EXPENSES........................................................................................................................... | 112 |
NOTE 32 | ASSETS CLASSIFIED AS HELD FOR SALE AND DISCONTINUED OPERATIONS AND | |
LIABILITES RELATED TO ASSET GROUPS CLASSIFIED AS HELD FOR SALE........................ | 112 | |
NOTE 33 | INCOME TAXES ................................................................................................................................... | 113-117 |
NOTE 34 | EARNING/LOSS PER SHARE.............................................................................................................. | 117 |
NOTE 35 | RELATED PARTY DISCLOSURES ..................................................................................................... | 118-120 |
NOTE 36 | FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES................................................ | 120-131 |
NOTE 37 | FINANCIAL INSTRUMENTS............................................................................................................... | 132-133 |
NOTE 38 | SHARES IN OTHER OPERATIONS .................................................................................................... | 133 |
NOTE 39 | SUBSEQUENT EVENTS....................................................................................................................... | 134-135 |
DOĞAN ŞİRKETLER GRUBU HOLDİNG A.Ş.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 30 SEPTEMBER 2022
(Amounts expressed in thousands of Turkish Lira ("TRY") unless otherwise indicated. Currencies other than TRY, expressed in thousands unless otherwise indicated.)
Unaudited | Audited | ||
Current Period | Prior Period | ||
ASSETS | Notes | 30 September 2022 | 31 December 2021 |
Current assets | 28,604,558 | 15,513,672 | |
Cash and cash equivalents | 6 | 5,135,584 | 4,646,127 |
Financial investments | 7 | 9,389,119 | 5,076,315 |
Trade receivables | |||
- Due from related parties | 35 | 23,156 | 5,136 |
- Due from non-related parties | 9 | 3,907,961 | 1,825,475 |
Receivables from finance sector operations | |||
- Due from related parties | 10, 35 | - | 44,064 |
- Due from non-related parties | 10 | 1,671,842 | 1,159,490 |
Balances with the Central Bank of | |||
the Republic of Turkey | 6 | 67,890 | 130,280 |
Other receivables | |||
- Due from non-related parties | 11 | 244,916 | 74,528 |
Inventories | 12 | 4,824,145 | 2,042,478 |
Prepaid expenses | 22 | 969,995 | 196,923 |
Derivative instruments | 23 | 99,114 | 46,920 |
Biological assets | 13 | 16,449 | 15,249 |
Other current assets | 21 | 400,731 | 250,387 |
Non-current assets classified | |||
as held for sale | 32 | 1,853,656 | 300 |
Non-current assets | 10,119,181 | 6,781,066 | |
Trade receivables | |||
- Due from non-related parties | 9 | 11,945 | 14,742 |
Receivables from finance sector operations | |||
- Due from non-related parties | 10 | - | 14,304 |
Financial investments | 7 | 949,144 | 364,930 |
Investments accounted for | |||
by the equity method | 4 | 461,298 | 264,140 |
Investment properties | 14 | 1,483,426 | 2,005,201 |
Property, plant and equipment | 15 | 3,287,087 | 2,035,484 |
Intangible assets | |||
- Other intangible assets | 16 | 2,336,617 | 1,228,999 |
- Goodwill | 16 | 411,926 | 108,843 |
Rights of use assets | 17 | 476,845 | 359,761 |
Prepaid expenses | 22 | 52,635 | 57,482 |
Derivative instruments | 23 | 64,309 | - |
Deferred tax asset | 33 | 526,266 | 138,916 |
Other non-current assets | 21 | 57,683 | 188,264 |
Total assets | 38,723,739 | 22,294,738 |
The consolidated financial statements as of and for the period ended 30 September 2022 have been approved by the Board of Directors on 8 November 2022.
The accompanying notes are an integral part of these consolidated financial statements.
1
DOĞAN ŞİRKETLER GRUBU HOLDİNG A.Ş.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2022
(Amounts expressed in thousands of Turkish Lira ("TRY") unless otherwise indicated. Currencies other than TRY, expressed in thousands unless otherwise indicated.)
Unaudited | Audited | ||
LIABILITIES | Notes | Current Period | Prior Period |
30 September 2022 | 31 December 2021 | ||
Short-term liabilities | 14,289,330 | 5,932,448 | |
Short-term borrowings | |||
- Short-term borrowings from non-related parties | 8 | 6,819,710 | 2,232,362 |
- Bank borrowings | |||
- Issued debt instruments | 8 | 799,970 | 270,161 |
Short-term portion of long- term borrowings | |||
- Short-term portion of long term borrowings from related parties | 8, 35 | 19,973 | 9,574 |
- Lease borrowings | |||
- Short-term portion of long- term borrowings from non-related parties | 8 | 1,253,263 | 651,787 |
- Bank borrowings | |||
- Lease borrowings | 8 | 101,588 | 55,301 |
Trade payables | 35 | 3,464 | 2,835 |
- Due to related parties | |||
- Due to non-related parties | 9 | 3,565,094 | 1,913,270 |
Payables from finance sector operations | 10 | 314,918 | 7,908 |
- Due to non-related parties | |||
Payables related to | 24 | 120,078 | 58,242 |
employee benefits | |||
Deferred income (Except obligations arising from customer contracts) | |||
- Deferred income from non-related parties | 22 | 388,690 | 123,015 |
(Except obligations arising from customer contracts) | |||
Derivative instruments | 23 | 9,642 | 17,776 |
Other payables | 3, 35 | - | 27,107 |
- Due to related parties | |||
- Due to non-related parties | 11 | 255,440 | 94,533 |
Liabilities related to asset groups classified as held for sale | 33 | 83,949 | - |
Current income tax liability | 115,329 | 411,958 | |
Short-term provisions | |||
- Short-term provisions for | 24 | 85,168 | 32,497 |
employment benefits | |||
- Other short-term provisions | 19 | 325,837 | 23,683 |
Other short term liabilities | 27,217 | 439 | |
Long-term liabilities | 3,643,889 | 2,042,610 | |
Long-term borrowings | |||
- Long-term borrowings from related parties | 8, 35 | 9,783 | 12,839 |
- Lease borrowings | |||
- Long -term borrowings from non-related parties | 8 | 2,070,823 | 1,207,435 |
- Bank borrowings | |||
- Lease borrowings | 8 | 396,163 | 217,841 |
Investments accounted for | 4 | 171,301 | 107,111 |
by the equity method | |||
Other payables | 11 | 87,290 | 5,149 |
- Due to non-related parties | |||
Deferred income (Except obligations arising from customer contracts) | |||
- Deferred income from non-related parties | 22 | 24,442 | 19,956 |
(Except obligations arising from customer contracts) | |||
Long-term provisions | |||
- Long-term provisions for | 24 | 187,627 | 103,326 |
employment benefits | |||
- Other long term provisions | 23 | 6,444 | 6,496 |
Derivative instruments | 12,463 | - | |
Deferred tax liability | 33 | 677,553 | 362,457 |
EQUITY | 20,790,520 | 14,319,680 | |
Equity attributable to equity holders of the parent company | 17,791,312 | 12,905,136 | |
Share capital | 25 | 2,616,938 | 2,616,938 |
Adjustments to share capital | 25 | 143,526 | 143,526 |
Repurchased shares (-) | 25 | (59,533) | (59,533) |
Share premiums (discounts) | 25 | 35,159 | 35,159 |
Other comprehensive income (losses) that | |||
will not be reclassified in profit or loss | |||
- Actuarial gains (losses) on | 25 | (29,422) | (29,422) |
defined benefit plans | |||
Shares not classified as profit or loss | |||
from other comprehensive income of | (1,347) | (1,347) | |
investments accounted for by equity method | |||
Other comprehensive income (losses) that | |||
will be reclassified in profit or loss | 25 | 3,315,295 | 2,155,915 |
- Change in currency translation reserves | |||
- Gain (loss) on revaluation and reclassification | 25 | (169,837) | (86,948) |
of financial assets held for sale | |||
Restricted reserves | 25 | 1,867,062 | 1,020,689 |
Retained earnings or accumulated losses | 5,940,204 | 4,281,683 | |
Net profit or loss for the period | 4,133,267 | 2,828,476 | |
Non-controlling interests | 2,999,208 | 1,414,544 | |
Total liabilities | 38,723,739 | 22,294,738 |
The accompanying notes are an integral part of these consolidated financial statements.
2
DOĞAN ŞİRKETLER GRUBU HOLDİNG A.Ş.
CONSOLIDATED STATEMENT OF PROFIT OR LOSS FOR THE INTERIM PERIODS 1 JANUARY - 30 SEPTEMBER 2022 AND 2021
(Amounts expressed in thousands of Turkish Lira ("TRY") unless otherwise indicated. Currencies other than TRY, expressed in thousands unless otherwise indicated.)
Unaudited | Unaudited | Unaudited | Unaudited | ||
Current Period | Current Period | Prior Period | Prior Period | ||
1 January - | 1 July - | 1 January - | 1 July - | ||
Notes | 30 September 2022 | 30 September 2022 | 30 September 2021 | 30 September 2021 | |
Profit or Loss | |||||
Revenue | 26 | 30,347,715 | 12,846,077 | 11,020,387 | 4,609,305 |
Revenue From Finance Sector Operations | 26 | 497,629 | 227,469 | 161,742 | 55,673 |
Total Revenue | 26 | 30,845,344 | 13,073,546 | 11,182,129 | 4,664,978 |
Cost of Sales (-) | 26 | (26,613,793) | (11,597,511) | (9,748,598) | (4,083,277) |
Revenue From Finance Sector Operations | 26 | (304,561) | (147,018) | (89,101) | (30,690) |
Total Cost of Sales | 26 | (26,918,354) | (11,744,529) | (9,837,699) | (4,113,967) |
Gross Profit/(Loss) (Non-Finance) | 26 | 3,733,922 | 1,248,566 | 1,271,789 | 526,028 |
Gross Profit/(Loss) (Finance) | 26 | 193,068 | 80,451 | 72,641 | 24,983 |
Gross Profit (Loss) | 26 | 3,926,990 | 1,329,017 | 1,344,430 | 551,011 |
Research and Development Expenses (-) | 27 | (21,744) | (17,808) | (5,373) | (1,570) |
General Administrative Expenses (-) | 27 | (536,610) | (210,201) | (267,627) | (87,980) |
Marketing Expenses (-) | 27 | (916,391) | (355,853) | (476,808) | (192,992) |
Other Income From Operating Activities | 29 | 2,194,363 | 840,829 | 575,999 | 101,018 |
Other Expenses From Operating Activities (-) | 29 | (414,687) | (215,158) | (187,818) | (35,700) |
Share of Gain (Loss) on Investments | |||||
Accounted for by the Equity Method | 4 | 133,038 | 2,855 | (5,124) | 3,007 |
Operating Profit/(Loss) | 4,364,959 | 1,373,681 | 977,679 | 336,794 | |
Income from Investment Activities | 30 | 2,555,238 | 1,545,688 | 572,579 | 93,095 |
Expenses from Investment Activities (-) | 30 | (414,729) | (348,357) | (11,808) | (152) |
Operating Profit (Loss) Before | |||||
Finance (Expense)/Income | 6,505,468 | 2,571,012 | 1,538,450 | 429,737 | |
Finance Expense (-) | 31 | (1,471,063) | (601,884) | (401,924) | (99,123) |
Profit/(Loss) Before Taxation | |||||
From Continued Operations | 5,034,405 | 1,969,128 | 1,136,526 | 330,614 | |
Tax Expense From | |||||
Continued Operations | 33 | (200,971) | (131,799) | (306,679) | (195,478) |
Tax Income/(Expense) for the Period | (495,863) | (102,573) | (285,852) | (174,850) | |
Deferred Tax Income/(Expense) | 294,892 | (29,226) | (20,827) | (20,628) | |
Profit/(Loss) For The Period | 4,833,434 | 1,837,329 | 829,847 | 135,136 | |
Allocation of Profit/(Loss) | |||||
For The Period | |||||
Attributable to Non-Controlling Interests | 700,167 | 198,722 | 109,960 | 46,367 | |
Attributable to Equity Holders of the | |||||
Parent Company | 4,133,267 | 1,638,607 | 719,887 | 88,769 | |
Gain/(Loss) Per Share Attributable | |||||
to Equity | |||||
Holders of the Parent Company | 34 | 1.596 | 0.633 | 0.277 | 0.034 |
The accompanying notes are an integral part of these consolidated financial statements.
3
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Dogan Sirketler Grubu Holding AS published this content on 16 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2022 14:28:00 UTC.